Cytek Biosciences (CTKB) Other Non-Current Assets (2020 - 2026)

Cytek Biosciences has reported Other Non-Current Assets for 7 years, with the latest figure at $6.3 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 37.87% year-over-year to $6.3 million; the trailing twelve-month figure through Mar 2026 stood at $6.3 million (up 37.87% YoY), and the FY2025 full-year result was $6.7 million, up 23017.24% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $6.3 million, down from $6.7 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $6.7 million in Q4 2025, with the low at $29000.0 in Q4 2024.
• Historically, Other Non-Current Assets has averaged $3.1 million across 5 years, with a median of $3.0 million in 2023.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets sank 99.0% — and 2025, when it surged 23017.24%.
• Cytek Biosciences' Other Non-Current Assets stood at $2.9 million in 2022, then tumbled by 88.58% to $331000.0 in 2023, then tumbled by 91.24% to $29000.0 in 2024, then surged by 23017.24% to $6.7 million in 2025, then retreated by 5.94% to $6.3 million in 2026.
• The last three Other Non-Current Assets figures came in at $6.3 million (Q1 2026), $6.7 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.